Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Healthy Subject Population”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06564389
What this trial is testing

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Who this might be right for
Healthy ParticipantsAtopic Dermatitis
Pfizer 119
Early research (Phase 1)Study completedNCT00432627
What this trial is testing

Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 24
Early research (Phase 1)Study completedNCT05224609
What this trial is testing

Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction

Who this might be right for
Moderate Hepatic ImpairmentSevere Hepatic ImpairmentHealthy Volunteers
Pfizer 21
Early research (Phase 1)Study completedNCT00759837
What this trial is testing

Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects

Who this might be right for
Breast CancerLeukemia, Myeloid, Chronic
Wyeth is now a wholly owned subsidiary of Pfizer 27
Early research (Phase 1)Looking for participantsNCT07231991
What this trial is testing

Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

Who this might be right for
Healthy Participants
Pfizer 24
Early research (Phase 1)Study completedNCT03920865
What this trial is testing

Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 26
Early research (Phase 1)Study completedNCT01027169
What this trial is testing

Assess the Effect of Hepatic Impairment on Safinamide Pharmacokinetics

Who this might be right for
Hepatic Impairment
Newron Pharmaceuticals SPA 24
Early research (Phase 1)Study completedNCT01149694
What this trial is testing

Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers

Who this might be right for
Ulcerative Colitis
PurGenesis Technologies Inc. 24
Not applicableStudy completedNCT02087566
What this trial is testing

Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)

Who this might be right for
Renal FailureImpaired Renal Function
Damanhour University 18
Early research (Phase 1)Study completedNCT04668066
What this trial is testing

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 121
Large-scale testing (Phase 3)Study completedNCT00223951
What this trial is testing

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

Who this might be right for
Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis
Vistakon Pharmaceuticals 900
Testing effectiveness (Phase 2)Study completedNCT02656043
What this trial is testing

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Who this might be right for
Acne Vulgaris
Xenon Pharmaceuticals Inc. 213
Not applicableStudy completedNCT00022997
What this trial is testing

Study of Taste Deficits

Who this might be right for
Taste DisorderHealthy
National Institute on Deafness and Other Communication Disorders (NIDCD) 450
Early research (Phase 1)Study completedNCT04136145
What this trial is testing

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 36
Early research (Phase 1)Study completedNCT03799848
What this trial is testing

A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Akebia Therapeutics 24
Early research (Phase 1)Study completedNCT01901133
What this trial is testing

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Who this might be right for
Pharmacokinetics of MDV3100Healthy SubjectsKidney Diseases
Astellas Pharma Europe B.V. 33
Early research (Phase 1)Study completedNCT07264335
What this trial is testing

A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects

Who this might be right for
Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 160
Early research (Phase 1)Study completedNCT06438263
What this trial is testing

Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

Who this might be right for
Atopic Dermatitis
Amgen 231
Early research (Phase 1)Study completedNCT02251132
What this trial is testing

Pharmacokinetics of Tipranavir Soft Elastic Capsules (SEDDS) and Ritonavir and Their Effects on Cytochrome P-450 (3A4) in Healthy Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 113
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation